Admission Date:  [**2153-1-23**]       Discharge Date:  [**2153-1-25**]   Service:  [**Hospital1 **]  HISTORY OF PRESENT ILLNESS:  The patient is an 80 year-old lady with a past medical history significant for diabetes, hypertension, hypothyroidism, coronary artery disease, who presents with pain and induration at Baclofen pump site.
She was admitted status post pump removal.
The patient's pump was placed [**2152-12-9**] and shortly after placement the patient developed fever and erythema.
The patient was on broad spectrum coverage with Ceftazidime and Vancomycin until several days before admission.
The patient called her physician on the day of admission to report on going erythema and fluctuance.
A decision was made to remove the pump and the patient was continued on broad spectrum antibiotics as stated above.
Coronary artery disease status post inferior myocardial infarction and percutaneous transluminal coronary angioplasty in [**2152-3-11**].
Glucophage 500 b.i.d.
Aspirin 81 mg q day.
Toprol XL 125 mg q day.
Lipitor 10 mg q.d.
Levoxyl 88 micrograms q day.
Folate 1 mg q day.
Multivitamin q day.
Colace 100 mg b.i.d.
99% oxygenation on room air.
The patient had wound gram stain as well as swab during pump removal, which showed 3+ polys and no organisms.
The patient was continued on Vancomycin as well as Ceftazidine for broad coverage.
A left PICC line was placed on the day of discharge for antibiotic infusion at the [**Hospital 228**] nursing home.
Coronary artery disease:  The patient is status post inferior myocardial infarction with percutaneous transluminal coronary angioplasty [**2152-3-11**].
She was continued on her aspirin, Metoprolol and Atorvastatin.
Hypertension:  The patient continued on Metoprolol with good blood pressures.
Incisional pain:  The patient was given Ketoralac as well as Tylenol for pain control.
Baclofen withdraw:  The patient was started on a po regimen of Baclofen to prevent withdraw after discontinuation of the patient's pump.
The patient was given prn Ativan 1 mg q 4 hours with good effect as well as a titration upward of her po Baclofen to 20 mg t.i.d.
Coronary artery disease status post percutaneous transluminal coronary angioplasty and inferior myocardial infarction.
MEDICATIONS ON DISCHARGE:  Same as upon admission with continuation of Vancomycin 1 gram b.i.d.
and Ativan 1 mg IV/PO prn with draw symptoms of rigidity, flushing, discomfort.
A new Baclofen pump is planned for eight weeks from now pending clearing of infection.
The patient will need dressing changes t.i.d.
with wound packing and wet to dry with saline.
